Dow Jones Futures: From AMD To Zoom Video, Growth Stocks Offer Warning; AbbVie To Buy AllerganInvestors Business Daily • 06/25/19
AbbVie confirms deal to buy Allergan for 45% premium, valuing Allergan at $61.7 billionMarket Watch • 06/25/19
Allergan's stock soars after WSJ report AbbVie near a buyout deal for a 45% premiumMarket Watch • 06/25/19
FDA approves Allergan's CoolTone device for toning up abdomen, buttocks and thighsMarket Watch • 06/24/19
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents DataZacks Investment Research • 06/19/19
Ironwood, Allergan Investors React Positively After Duo's Constipation Drug Found EffectiveBenzinga • 06/19/19
Allergan stock jumps 3.8% after Evercore ISI analyst says company is likely heading toward a splitMarket Watch • 06/18/19
Allergan (AGN) Down 9.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/06/19